SEELOS THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Seelos Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q1 2024.
  • Seelos Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $23K, a 229% increase year-over-year.
  • Seelos Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $91K, a 550% increase year-over-year.
  • Seelos Therapeutics, Inc. annual Interest Expense for 2023 was $75K, a 436% increase from 2022.
  • Seelos Therapeutics, Inc. annual Interest Expense for 2022 was $14K, a 99.1% decline from 2021.
  • Seelos Therapeutics, Inc. annual Interest Expense for 2021 was $1.6M, a 874% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $91K $23K +$16K +229% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $75K $19K +$19K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $56K $42K +$40K +2000% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $16K $7K +$2K +40% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $14K $7K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $14K $0 -$5K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $19K $2K -$18K -90% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $37K $5K -$578K -99.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $615K $7K -$983K -99.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.6M $5K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $20K +$14K +233% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $583K +$580K +19333% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $990K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $6K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $3K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q2 2012 $168K +$83.1K +97.4% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $174K +$62.6K +56.5% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-10
Q2 2011 $85.3K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $111K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.